According to the World Health Organisation (WHO), the following group of people should be treated: (1) Everybody with an Aspartate aminotransferase/platelet ratio (APRI) score >2 (evidence of cirrhosis) irrespective of ALT and HBV DNA levels. This evidence concerns the gene GPT and Cirrhosis.